Sangamo Therapeutics announces pricing of public offering of common stock
Sangamo announced pricing of an underwritten public offering of 12,310,000 shares of its common stock at a price to the public of $16.25 per share. Gross proceeds are expected to be $200.0 million. Sangamo granted underwriters a 30-day option to purchase up to an additional 1,846,500 shares. April 25, 2018